Your session is about to expire
← Back to Search
Estetrol for Hot Flashes in Menopause
Study Summary
This trial is testing a new hormone to treat hot flashes and other menopause symptoms. It is testing how well it works and how safe it is.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have systemic lupus erythematosus.You have a serious mental health condition that requires ongoing treatment.You are experiencing hot flashes or other symptoms related to menopause and are seeking treatment to alleviate them.You had a mammogram done in the last 9 months and it did not show any significant signs of disease.Women who are between 40 and 65 years old at the time of selection.If you have had your uterus removed, it must have been at least 6 weeks before the screening for this study. It doesn't matter if only part of the uterus was removed.You experience hot flashes or night sweats at least once a week at a moderate to severe level.You experience at least one moderate to severe hot flash per week.You have a history of drug or alcohol abuse within the last year as determined by the researcher. This includes marijuana, even if it is legal in your state.You have participated in another clinical trial involving an experimental drug or have taken an experimental drug in the past month.If you are a woman who has not had a hysterectomy, you cannot participate if you have a known allergy to peanuts.You must have a body mass index between 18.0 and 38.0 kg/m².You smoke more than 15 cigarettes per day.You have or had a problem with your gallbladder, unless you have had your gallbladder removed.You have taken phytoestrogens or black cohosh for hot flashes in the last 2 weeks before the screening.You have a history of allergic reactions or intolerance to the investigational drug or drugs similar to it.You experience at least 7 moderate to severe hot flashes or 50 moderate to severe hot flashes per week for the past week.You have read and signed a document that explains the study, and you agree to participate in it.If you haven't had a hysterectomy, the lining of your uterus measured by ultrasound should be less than 4mm.If you still have your uterus, you need to have a biopsy taken during screening to check for any abnormal conditions like cancer, pre-cancerous changes, or abnormal tissue growth. The biopsy must provide enough tissue for a proper diagnosis.Your body weight is within a specific range based on your height, and you are not too underweight or overweight.You are experiencing menopause-related symptoms such as hot flashes, and are seeking treatment to alleviate them.You experience at least 7 significant hot flashes per day or 50 significant hot flashes per week consistently for the past week.You have had cancer before, except for non-serious skin cancers like basal cell or squamous cell carcinoma that were treated more than a year ago.You have unexplained vaginal bleeding or unusual bleeding from your uterus.You have had a procedure called endometrial ablation.
- Group 1: Estetrol 15 mg -Efficacy Part
- Group 2: Estetrol 20 mg -Efficacy Part
- Group 3: Placebo - Efficacy Part
- Group 4: Estetrol 20 mg + P4 100 mg - Safety Part
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are investigators actively searching for new participants?
"That is correct. Currently, the clinical trial is looking for 1500 participants from 39 different locations. The information was originally posted on December 30th, 2019 and was last edited on May 9th, 2022."
Has the Progesterone oral tablet undergone FDA approval?
"Progesterone oral tablet received a safety score of 3 because this medication has cleared multiple rounds of testing with positive results."
Are there many Progesterone oral tablet clinical trials?
"Progesterone oral tablet was first researched in 1996 at the National Institutes of Health Clinical Center. A total of 265 clinical trials have completed since then, with 46 more active trials currently underway. Many of these studies are based out of Las Vegas, Nevada."
Are only senior citizens able to participate in this experiment?
"In order for patients to be included in this particular trial, they must fall between the ages of 40-65. There are 11 other trials that cater to those under 18 and 25 additional ones for adults over 65."
Progesterone is regularly taken to treat which condition?
"Progesterone is frequently used to treat amenorrhea, but it can also help with uterine bleeding, hormonal imbalances, and preventing preterm births."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger